Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study. (Q33343777)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

R K C Ngan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

H H Y Yiu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

W H Lau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S Yau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

F Y Cheung

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C H Kwok

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C Y Chiu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S K Au

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

W Foo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C K Law

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

K C Tse

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

1252-1258

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF200

Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF200

Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF200

Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF200

Outpatient weekly chemotherapy in patients with nasopharyngeal carcinoma and distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF200

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF200

Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF200

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF200

A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF200

Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF200

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDF200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12181249%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference